Asset Details
Do you wish to reserve the book?
Assessment of Extracellular Genomic and Mitochondrial DNA in Follicular Fluid of Women Depending on the Type of Final Oocyte Maturation Trigger in ART Programs
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Assessment of Extracellular Genomic and Mitochondrial DNA in Follicular Fluid of Women Depending on the Type of Final Oocyte Maturation Trigger in ART Programs
Do you wish to request the book?
Assessment of Extracellular Genomic and Mitochondrial DNA in Follicular Fluid of Women Depending on the Type of Final Oocyte Maturation Trigger in ART Programs
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Assessment of Extracellular Genomic and Mitochondrial DNA in Follicular Fluid of Women Depending on the Type of Final Oocyte Maturation Trigger in ART Programs
2025
Overview
We compared the content of extracellular genomic and mitochondrial DNA (ec-gDNA and ec-mtDNA) in the follicular fluid (FF) of women after using two types of triggers for final oocyte maturation: human chorionic gonadotropin (hCG) and gonadotropin-releasing hormone agonist (GnRHa). The study included 43 women aged 21-35 years with preserved ovarian reserve according to hormonal profile and ultrasound examination, who were divided into two groups depending on the type of trigger: hCG at a dose of 10,000 IU (group 1;
n
= 30) and GnRHa at a dose of 0.2 mg (group 2;
n
= 13). From each patient, a sample of FF was obtained during transvaginal puncture from a dominant follicle without blood admixture. The content of ec-gDNA and ec-mtDNA was measured by qPCR. At the first stage, a positive correlation was found between the content of ec-gDNA and ec-mtDNA and the level of anti-Müllerian hormone, as well as between the level of ec-mtDNA and the number of oocytes. In patients reveiving GnRHa, the level of ec-mtDNA was significantly higher. There were no significant differences between the groups in the level of free ec-gDNA. The identified differences in ec-mtDNA in FF not only indicate different mechanisms of action of the used drugs, but also offer hope for the development of more precise approaches to the use of FF at the embryological stage of ART infertility treatment programs.
Publisher
Springer US,Springer,Springer Nature B.V
Subject
/ Anti-Mullerian Hormone - metabolism
/ Biomedical and Life Sciences
/ Chorionic Gonadotropin - pharmacology
/ DNA, Mitochondrial - genetics
/ DNA, Mitochondrial - metabolism
/ Female
/ Follicular Fluid - drug effects
/ Follicular Fluid - metabolism
/ Genomics
/ Gonadotropin-releasing hormone
/ Gonadotropin-Releasing Hormone - agonists
/ Hormones
/ Humans
/ In Vitro Oocyte Maturation Techniques
/ Oocytes
/ Oocytes - growth & development
/ Ovarian Follicle - drug effects
